| Primary |
| Drug Use For Unknown Indication |
32.1% |
| Urinary Tract Infection |
14.9% |
| Product Used For Unknown Indication |
11.5% |
| Unevaluable Event |
7.1% |
| Infection |
4.2% |
| Prophylaxis |
3.8% |
| Hypertension |
3.0% |
| Cystitis |
2.9% |
| Prostatitis |
2.9% |
| Pyrexia |
2.4% |
| Bronchitis |
2.1% |
| Pneumonia |
1.8% |
| Pyelonephritis |
1.8% |
| Pseudomonas Infection |
1.6% |
| Diverticulitis |
1.5% |
| Sinusitis |
1.5% |
| Respiratory Tract Infection |
1.4% |
| Sepsis |
1.4% |
| Diarrhoea |
1.1% |
| Bacterial Infection |
1.1% |
|
| Tendon Rupture |
9.8% |
| Pain In Extremity |
9.3% |
| Tendonitis |
9.3% |
| Vomiting |
9.1% |
| Tendon Pain |
8.6% |
| Renal Failure Acute |
6.4% |
| Rash |
4.7% |
| Arthralgia |
4.4% |
| Thrombocytopenia |
4.2% |
| Hypersensitivity |
3.7% |
| Tendon Disorder |
3.7% |
| Tremor |
3.4% |
| Myalgia |
3.2% |
| No Adverse Event |
3.2% |
| Urticaria |
3.2% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Paraesthesia |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
| Nausea |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.5% |
| Product Used For Unknown Indication |
21.0% |
| Urinary Tract Infection |
7.6% |
| Pneumonia |
5.4% |
| Hypertension |
4.2% |
| Prophylaxis |
3.0% |
| Sepsis |
3.0% |
| Immunosuppression |
2.8% |
| Infection |
2.7% |
| Antibiotic Prophylaxis |
2.7% |
| Pain |
2.7% |
| Arthritis |
2.6% |
| Musculoskeletal Pain |
2.6% |
| Sinus Disorder |
2.6% |
| Bronchopulmonary Aspergillosis |
2.5% |
| Diabetes Mellitus |
2.1% |
| Infection Prophylaxis |
2.0% |
| Pyrexia |
1.9% |
| Pseudomonas Infection |
1.6% |
| Ill-defined Disorder |
1.4% |
|
| Toxic Epidermal Necrolysis |
12.0% |
| Renal Failure Acute |
8.8% |
| Thrombocytopenia |
8.8% |
| Tendonitis |
7.2% |
| Tendon Rupture |
6.8% |
| Renal Failure |
6.0% |
| Vomiting |
6.0% |
| Pyrexia |
5.2% |
| Drug Hypersensitivity |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Multi-organ Failure |
4.0% |
| Toxic Skin Eruption |
3.6% |
| Liver Disorder |
3.2% |
| Rash |
3.2% |
| Rash Maculo-papular |
3.2% |
| Loss Of Consciousness |
2.8% |
| Sepsis |
2.8% |
| Tendon Disorder |
2.8% |
| Ulcer |
2.8% |
| Acute Generalised Exanthematous Pustulosis |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.8% |
| Product Used For Unknown Indication |
15.7% |
| Prophylaxis |
10.7% |
| Crohn's Disease |
8.3% |
| Hypertension |
5.9% |
| Pain |
5.3% |
| Multiple Myeloma |
4.8% |
| Nausea |
3.3% |
| Hiv Infection |
2.9% |
| Urinary Tract Infection |
2.6% |
| Infection Prophylaxis |
2.5% |
| Constipation |
2.3% |
| Infection |
2.3% |
| Stem Cell Transplant |
2.1% |
| Contraception |
2.1% |
| Depression |
2.0% |
| Pyrexia |
1.9% |
| Premedication |
1.9% |
| Adult T-cell Lymphoma/leukaemia |
1.8% |
| Acute Lymphocytic Leukaemia |
1.8% |
|
| Vomiting |
10.6% |
| Pulmonary Embolism |
7.7% |
| Pyrexia |
7.3% |
| Urinary Tract Infection |
6.9% |
| Renal Failure |
5.7% |
| Pneumonia |
5.5% |
| Pain |
5.3% |
| Renal Failure Acute |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Febrile Neutropenia |
5.1% |
| Sepsis |
4.6% |
| Death |
4.2% |
| Thrombocytopenia |
4.2% |
| Septic Shock |
3.7% |
| Weight Decreased |
3.5% |
| Crohn's Disease |
3.1% |
| Syncope |
3.1% |
| Weight Increased |
3.1% |
| Deep Vein Thrombosis |
2.9% |
| Diarrhoea |
2.9% |
|
| Interacting |
| Infection |
16.1% |
| Drug Use For Unknown Indication |
8.0% |
| Graft Versus Host Disease |
6.9% |
| Hypertension |
6.9% |
| Sepsis |
5.7% |
| Atrial Fibrillation |
4.6% |
| Endocarditis |
4.6% |
| Pancytopenia |
4.6% |
| Pyrexia |
4.6% |
| Pyuria |
4.6% |
| Thrombosis Prophylaxis |
4.6% |
| Anaemia |
3.4% |
| Diabetic Foot Infection |
3.4% |
| Emotional Distress |
3.4% |
| Mental Disorder |
3.4% |
| Nasopharyngitis |
3.4% |
| Prophylaxis |
3.4% |
| Thrombophlebitis |
3.4% |
| Abdominal Pain Upper |
2.3% |
| Cardiac Failure |
2.3% |
|
| International Normalised Ratio Increased |
12.1% |
| Drug Interaction |
9.1% |
| Epilepsy |
9.1% |
| Toxic Epidermal Necrolysis |
9.1% |
| Respiratory Failure |
6.1% |
| Subdural Haematoma |
6.1% |
| Urticaria |
6.1% |
| White Blood Cells Urine Positive |
6.1% |
| Chest Pain |
3.0% |
| Hallucination |
3.0% |
| Homicide |
3.0% |
| Hypochromic Anaemia |
3.0% |
| Hypoglycaemia |
3.0% |
| Hypoxia |
3.0% |
| Lethargy |
3.0% |
| Liver Function Test Abnormal |
3.0% |
| Malaise |
3.0% |
| Pancytopenia |
3.0% |
| Pneumonia Aspiration |
3.0% |
| Rash Macular |
3.0% |
|
